JAK1 and vitiligo: Targeting these molecules in this pathway, including IFN-γ, the IFN-γ receptor, JAK1 and JAK2, signal transducer and activator of transcription (STAT)1, CXCL10, and CXCR3, may be appealing therapy in vitiligo (49, 50).